We studied the uptake of labeled dexamethasone CH-Dex) or methylprednisolone I'H-MP) in isolated perfused cat hearts during the first hour of acute myocardial ischemia. Considerable amounts of 'H-Dex and 'H-MP were taken up by toe plasma membrane (F,) fraction in control, border zone, and ischemic myocardial tissue. Lesser amounts were incorporated into the remaining cell fractions. A gradient of glucocorticoid uptake was observed that decreased from control tissue to ischemic tissue in all subcellular fractions (i.e., F, to F,). Accordingly, supernatant fraction (S) to particulate (P) ratios of labeled glucocorticoid uptake increased from control to ischemic tissue, indicating that myocardial cell damage resulted in a decrease in glucocorticoid-binding capacity in subcellular fractions obtained from ischemic tissue. The activity of S'-nucleotidase (S'ND), a plasma membrane marker in myocardial cells, also decreased from normal to ischemic tissue. Furthermore, we found that uptake of 'H-MP and 'H-Dex was associated with toe retention of 5'ND activity in F, fractions of both border zone and ischemic tissue. Similar protection of plasma membrane integrity occurred in the supernatant fraction as determined by changes in S/P ratios of S'ND activity. These data provide support for the concepts that (I) plasma membrane changes occur soon after acute myocardial ischemia, and (2) the mechanism by which glucocorticoids exert a protective effect in myocardial ischemia may be related to membrane stabilization.
PHARMACOLOGICAL DOSES of glucocorticoids, such as dexamethasone (Dex) and methylprednisolone (MP) have been shown to diminish or retard myocardial cell damage during acute myocardial ischemia. 1 -* Recently, MP has been found to reduce predicted infarct size in patients with acute myocardial infarction. 1 These studies are of considerable interest, but have not identified a mechanism of action of the glucocorticoid.' • ' Although Vyden et al. 4 showed that MP reduced arterial blood pressure and coronary flow in dogs subjected to myocardial infarction, the changes were small and of short duration. More recently, Beardsley et al. 5 studied the effects of glucocorticoids on cardiodynamics under carefully controlled conditions in th perfused cat heart. Neither Dex nor MP exerted a significan effect on contractile force, coronary flow, myocardia oxygen consumption, incidence of arrhythmias, or heart rate." Spath et al. 1 showed that MP retarded lysosomal and cytoplasmic enzyme release in acute myocardial ischemia and suggested that the mechanism of the protective effect was one of membrane stabilization. Unfortunately, no data are available on the uptake of glucocorticoids in ischemic cardiac tissue or on the subcellular localization of glucocorticoids within ischemia myocardial cells. The purposes of this study were (I) compare the uptake of labeled glucocorticoid in ischemic and nonischemic cardiac tissue, (2) determine the subcellular loci for glucocorticoid uptake in myocardial cells, and (3) relate the glucocorticoid uptake to membrane integrity of both ischemic and nonischemic cardiac tissue.
Methods
[l,2-'H]Dexamethasone ('H-Dex), 25 Ci/mmol, and 3 Hsorbitol, 1.7 Ci/mmol, were obtained from Amersham/ Searle and methylprednisolone-'H-21-sodium succinate ('H-MP), 31 Ci/mmol, from New England Nuclear. Unlabeled Dex sodium phosphate (Decadron) was supplied by Merck Sharp & Dohme, and unlabeled MP sodium succinate (Solu-Medrol) was provided by Upjohn. All other chemicals were of reagent grade and were obtained from standard sources.
PERFUSION OF ISOLATED CAT HEARTS
Cats of either sex were anesthetized with sodium pentobarbital (30 mg/kg, iv), and their hearts (weighing 15.0 ± 0.5 g, mean ± SEM) were removed via a midventral thoracotomy and transferred to a Langendorff perfusion apparatus as previously described.' Retrograde perfusion was accomplished through the aorta with Krebs-Henseleit solution containing 10 mM glucose. Perfusate temperature was maintained at 37°C and the Krebs-Henseleit solution was gassed with a mixture of 95% O i and 5% CO i throughout the perfusion period. Hearts were perfused initially for 10 minutes at a perfusion pressure of 50 mm Hg without recirculation to remove trapped blood from the coronary vasculature. The hearts then were perfused at a constant flow of 25 ml/min for a period of 60 minutes. Hearts were randomly assigned into nonischemic and ischemic groups. In the ischemic group, the left anterior coronary artery was doubly ligated 2-3 mm distal to its bifurcation and the artery was cut between the ligatures. Ischemic tissue was obtained from the area supplied by the occluded artery, and border zone tissue was obtained from the adjacent area. In the nonischemic group, coronary occlusion was not induced, but samples of nonischemic myocardium were obtained from the same area as that used for ischemic tissue in the ischemic group. Ischemic tissue could be identified by its cyanotic appearance. Periodically, Evans blue was injected into the aortic cannula. The absence of dye for 30-60 seconds identified the ischemic area. However, the dye could not be used routinely because it interfered with the sucrose gradient. The concentrations of Dex and MP wereO.171 miu (specific activity of 1,170 jtCi/mmol) and 0.805 IDM (497 fiCi/mmol), respectively. After perfusion with 500 ml of Krebs-Henseleit solution for 60 minutes, the hearts were flushed with 200 ml of ice-cold Krebs-Henseleit solution via the aortic cannula to exchange most of the label in the extracellular fluid. Samples of nonischemic, border zone, and ischemic myocardium, each of which weighed 100-200 mg, were excised from the respective areas, finely minced, and placed in scintillation vials containing 10 ml of Multisol counting solution (Isolab). The tissues were homogenized with a Polytron PT-10 homogenizer (Brinkmann Instruments) for 60 seconds. Radioactivity of perfusates and tissue extracts was counted in a Packard liquid scintillation spectrometer; quenching was determined by an external standard method. This protocol yielded a counting efficiency of approximately 30%.
PREPARATION OF MYOCARDIAL SUBCELLULAR PARTICLES
The preparation of subcellular particles is outlined in Figure 1 . Sucrose density gradients were prepared according to the method of Kidwai 7 using a Gradient Former model 570 (Instrumentation Specialties). The gradient tubes were left at 4°C for at least 12 hours before use. Two grams of heart muscle were cut into 1-mm pieces with razor blades, and homogenized, in 4 ml of 0.25 M sucrose in Polytron PT-20 for 20 seconds at a speed setting of 7.5.
Homogenates were adjusted to 1:10 (wt/vol) by adding appropriate volumes of 0.25 M sucrose. Homogenates were centrifuged at 600 g for 10 minutes at 4°C. The residue containing nuclei, myofibrils, and cellular debris was discarded. The supernatant fraction (S,) was then centrifuged at 105,000 g for 2 hour in a model B-35 International ultracentrifuge equippe with a swinging-bucket rotor SB-283. The resultant supecnatant fraction (S,) was designated as the soluble (S) cytoplasmic fraction and the pellet as the particulate (P) fraction.
The particulate fractions were resuspended in 1.5 ml of ice-cold 0.25 M sucrose, layered on top of the sucrose gradient, and centrifuged for 90 minutes at 112,000 g at 4°C. The formed bands, operationally defined as F, to F 5 , were collected using an Instrumentation Specialties model 183 density fractionator. Isopyknic density profiles of the bands were determined by weighing 0.10-ml fractions of the gradient of representative tubes run in parallel. The isopyknic densities and positions of the five bands are summarized in Figure 2 .
DETERMINATION OF EXTRACELLULAR FLUID SPACE
Extracellular space (ECS) of the heart muscle was determined by perfusing other hearts for 60 minutes with 10 mM sorbitol having a specific activity of 50 ^Ci/mmol using Krebs-Henseleit solution as the perfusate. Total ECS was defined as the sorbitol space measured before flushing the coronary beds, and the nonexchangeable portion of the ECS as that measured after flushing with 200 ml of Krebs-Henseleit solution. Radioactivity of the labeled heart muscle was determined as above.
THIN LAYER CHROMATOGRAPHY OF GLUCOCORTICOID
For this type of study, hearts were labeled with MP and homogenized as above. Glucocorticoid was extracted from
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Isopycnic Densities g/ml tissue homogenates into an equal volume of chloroform. The chloroform phase was recovered after centrifugal separation followed by evaporation to dryness under 100% nitrogen. The residues were dissolved in 0.1 vol of methanol. Samples were applied to silica gel thin layer chromatographic plates (TLC 5097, Quantum Industries) and developed in a solvent system composed of ethyl acetate-methanol-ammonium hydroxide (75:25:2, v/v/v). The labeled compound dissolved in K-H solution at the same concentration was processed similarly and applied to the TLC as reference standard. After development, the silica gel was scraped at I-cm intervals from the plate and added to Multisol for isotopic counting.
CHEMICAL DETERMINATIONS
Proteins of subcellular fractions were measured according to the method of Lowry et al., * and those of tissue fractions by the microbiuret method of Gornall et al.* using bovine albumin as standard.
5'-Nucleotidase activity was measured spectrophotometrically as an index of cell membrane integrity. AMP was used as substrate according to the method of Song and Bodansky, 10 and specific activities are expressed as ng P, formed per hour per mg of protein. Cathepsin D activities were assayed according to the method of Anson" using bovine hemoglobin as substrate. Figure 3 summarizes the uptake of tritiated MP and Dex by the three areas of cardiac tissue in perfused cat hearts. Both glucocorticoids were taken up by normal cardiac tissue to a considerable extent (i.e., about 1-1.5 ^mol/g of tissue). The uptake of glucocorticoid in the border zone was not significantly different from that of control nonischemic tis- sue, although it was about 10-12% lower than in control myocardial tissue. In contrast, uptake of both glucocorticoids was significantly lower in ischemic tissue (P < 0.001) than in control tissue. Nevertheless, ischemic tissue took up large amounts of glucocorticoid (i.e., 66-73% of control tissue). These results indicate that despite the marked degree of regional ischemia (i.e., total occlusion produced by dividing the artery), significant uptake of glucocorticoid occurred.
Results

FIGURE 3 Comparison of uptake of'H-dexamethasone ( * H-Dex) and 'H-methylprednisolone {'H-MP) by control, border zone, and ischemic cardiac tissue. Hearts were perfused al 37"C for 60 minutes by recirculation of 500 ml of Krebs
Since the uptake of glucocorticoids by cardiac tissue included those distributed extracellularly, the extent of this extracellular fraction was estimated by determining the size of the ECS under the present experimental conditions. The total left ventricular ECS was 34.6 ± 0.9% (mean ± SEM) and the nonexchangeable ECS was 10.6 ± 0.7% for 16 measurements. From these data, together with assumption that the concentration of extracellular glucocorticoids is equal to that of the perfusate, it is clear that the majority of myocardial steroid uptake (i.e., 94-98%) is intracellular or is associated with membrane components, and only 2-6% of the uptake is estimated to be extracellular.
To examine the stability of the synthetic glucocorticoid taken up by cardiac tissue, homogenates of ischemic and border zone myocardium were extracted and chromatographed. On TLC, 95-97% of the radioactivity extracted from tissue samples were recovered in a sharp single peak with a retardation factor (R f ) value of 0.53 identical to that of reference standard, and less than 4% of the radioactivity in the origin. The results indicate a very high degree of purity of the test compounds without evidence that any appreciable degree of metabolic breakdown of the label took place in cardiac tissue during the 1-hour observation period.
To differentiate steroid uptake by subcellular organelles from that in the soluble cytoplasmic fraction, the supernatant-particulate ratio (S/P) of the 105,000-£, 2-hour centrifugation was determined. This ratio yields information on the extent of steroid uptake by membranous components of the myocardial cells in three areas of myocardial tissue. Figure 4 summarizes these data for both Dex and MP in perfused cat hearts. Both glucocorticoids exhibited S/P ratios of 7-10 in control myocardial tissue, indicative of a considerable amount of particulate-bound steroid in these regions. The S/P ratios in the border zone were slightly but not significantly higher than in normal tissue. However, both glucocorticoids exhibited a significantly higher S/P ratio (P < 0.001) in the ischemic area.
Of considerable interest is the intracellular distribution of the glucocorticoids in the five subcellular fractions. Table 1 summarizes the absolute specific uptakes in each fraction expressed in nmol/mg of protein. The most striking finding in control tissue is the large uptake of glucocorticoid in the cell membrane fraction which constitutes 70-85% of the total paniculate uptake for both steroids. The absolute uptake of glucocorticoid by cell membranes was significantly lower in the border zone and in ischemic tissue {P < 0.01). There was a progressively lower absolute uptake with each successive subcellular fraction. Thus, F, > Fj > F 3 > F 4 > F, for glucocorticoid uptake in all three zones. Despite the spreading of lysosomes over the F,, F,, and F« fractions, considerable glucocorticoid uptake was found in these fractions in all three cardiac ^areas^ Apparently, lysosomes and other particles take up glucocorticoid, although to a significantly lesser extent than do cell membranes. Another way of expressing the uptake of glucocorticoids by myocardial cell fractions is by percent distribution among the five subcellular fractions. Figure 5 depicts the percent of total paniculate glucocorticoid uptake in the three cardiac areas for the five subcellular fractions. The major points are, first, that all three areas (i.e., normal, border, ischemic) exhibit remarkably similar uptakes in all five subcellular fractions; this holds true for both Dex and MP. Second, the basic gradient of uptake also exists when the data are plotted in this manner (i.e., F, > F, > F ! > F 4 > F 6 ). However, there is a higher uptake of MP in the F| and F 4 fractions (i.e. lysosomes and mitochondria) than of Dex.
In an attempt to quantif the rate of glucocorticoid uptake to the degree of integrity of cell membranes, a series of cat hearts was perfused in the presence or absence of tritiated glucocorticoid, and the activity of the plasma membrane marker 5'ND was determined in each fraction. The most obvious finding to emerge from these data was that virtually all the 5'ND activity is present in the F, fraction. Only 10-20% of the activity was found in the F, fraction and trace amounts occurred in the other three fractions (i.e., F J -F J ) . This distribution occurred in both normal and ischemi(T regions oT tne^ heart 7 This indicates-that the f 1 , fraction comprises most of the plasma membranes of the myocardial cell homogenate, since this enzyme is relatively tightly bound to plasma membranes. Figure 6 summarizes the specific activities of 5'ND of the cardiac F : fraction in the different experimental groups. Ischemia results in a significant (P < 0.001) decrease in 5'ND activity from about 15 to 5 U/mg protein. The 5'ND activity in border zone tissue is midway between these two values (i.e., about 10 U/mg protein), being significantly different (P < 0.001) from both control and ischemic tissue. Each glucocorticoid was able to retard this decrease in 5'ND activity in the Fi fractions of ischemic and border zone tissue. Thus the border zone 5'ND activity in steroid-treated hearts was not significantly different from control tissue, but was significantly higher than border zone tissue in nonsteroid-treated hearts (P < 0.025). Similarly, ischemic tissue F t fractions obtained from glucocorticoid-treated hearts exhibited significantly higher 5'ND activities than non-steroid-treated hearts (P < 0.025). The 5'ND activities of the ischemic area F, fractions in steroid-treated hearts were not significantly different from the 5'ND activity in F, fractions obtained from the border zone in non-steroidtreated hearts. In addition, the relative proportions of 5'-ND activity between the supernatant fraction and particulate fraction for the three different cardiac areas and for the steroid-perfused and non-steroid-perfused hearts are shown in Table 2 . The data indicate that in the absence of glucocorticoid, 62% of the 5'ND activity is found in the soluble fraction of ischemic cardiac tissue and 23% of the activity occurs in border zone supernatant fraction. However, this activity was only 33-34% and 5-6% of the total in ischemic and border zone tissue, respectively, in the presence of glucocorticoid.
Discussion
Glucocorticoids are agents in myocardial ischemia, 1 ' 2 in acute tnyocardial infarction, * 1 and in y shock." However, not all to be useful therapeutic investigators agree that glucocorticoids are effective in preventing the extension of the developing infarct in myocardial ischemia. 14 Also, there is a diversity of opinion regarding the efficacy and mechanism of the protective action. Moreover, there is a question of whether glucocorticoids reach the ischemic myocardial region in order to exert a direct membranestabilizing effect locally or whether they exert an indirect action at a site distant from the ischemic tissue (e.g., altered sinoatrial node firing to modulate heart rate). Therefore, useful information can be obtained concerning the distribution of glucocorticoid within myocardial cells. Finally, correlation of the subcellular localization of glucocorticoid with some index of structural or functional integrity of subcellular organelles could provide information on the mechanism of action of the steroids in myocardial ischemia.
Several mechanisms have been suggested for the beneficial action of glucocorticoids on ischemic myocardial tissue, indicating that they (1) dilate coronary vessels, 4 (2) decrease myocardial oxygen demand (e.g., by reduction of cardiac afterload), 4 (3) diminish cardiac arrhythmias, 15 (4) open coronary collateral vessels, 1 "-17 (5) make available more energy for myocardial cells, and (6) stabilize cell membranes (e.g., plasma and lysosomal membranes). We have shown previously" that neither MP nor Dex exerts any sustained significant inotropic, chronotropic, coronary vasodilator, cardiac oxygen-sparing, or antiarrhythmic effect in the isolated perfused cat heart under conditions virtually identical to those employed in this study. Moreover, others have shown that pharmacological doses of glucocorticoids failed to exert antiarrhythmic 12 or vasoactive 4 -12 effects. This is consistent with a lack of hemodynamic effects of glucocorticoids in a variety of normal and disease states. 1 ' Nevertheless, even if hemodynamic mechanisms are not involved in the myocardial tissue salvage action, there is insufficient evidence to establish a membrane-stabilizing mechanism of action. The major evidence presently available for membrane stabilization is the finding of a decreased loss of lysosomal enzymes from ischemic myocardial tissue in the presence of glucocorticoid. 1 ' 2 Corroborating this finding was the greater degree of lysosomal stability (i.e., lower percent free cathepsin D activity) in ischemic myocardial tissue obtained from cats treated with MP. 1 These findings were interpreted as a stabilizing effect on lysosomal membranes, or cell membranes or both, but direct evidence to support this contention was not available.
The data presented in this report indicate that Dex and MP are taken up in substantial amounts by normal, ischemic, and border zone myocardial tissue when circulating in high concentrations. This confirms the preliminary findings of Beardsley et a l . " in cat heart slices. The data suggest that glucocorticoids may be able to preserve the integrity of plasma membranes of myocardial cells even in the presence of the severe disturbances occurring during myocardial ischemia.
The fact that ischemic and border zone myocardial tissue takes up considerable amounts of glucocorticoid indicates that either (1) glucocorticoids penetrate myocardial membranes readily, (2) cat myocardium has considerable collateral coronary blood vessels, or (3) both mechanisms are operative. Previously, dye injection studies showed that cat myocardium has a large collateral coronary network during normal and ischemic states (unpublished observations). In this regard, glucocorticoids also are known to readily penetrate somatic cells. 10 We are not able to determine the relative contributions of rtiese two factors to the uptake of glucocorticoid by ischemic myocardial cells. In this connection, virtually all the glucocorticoid counts (i.e., 95-97%) in myocardial cells present 1 hour after the onset of perfusion is native steroid rather than steroid metabolites. Thus, myocardial tissue does not actively degrade corticosteroids. This finding ionfirms the earlier work of Travis and Sayers !1 that cardiac tissue metabolizes corticosteroids only to a very slight degree (i.e., less than 10%) over a period of 2-3 hours.
We observed a significant decrease in 5'ND activity in membrane fractions in ischemic myocardial tissue. This enzyme is tightly bound to myocardial cell plasma membranes and does not occu other myocardial cell organelles to any appreciabl This finding may indicate damage to myocardia membranes and that less intact membrane is presen after an ischemic episode. Alternatively, the decreased 5'ND activity may occur in an intact membrane, the reduced activity resulting from a change in membrane structure having significant functional implications. Finally, the reduced 5'ND activity may merely be a result of reduced protein synthesis or some other metabolic process not necessarily related to membrane integrity.
At present, we cannot decide which alternative is the correct explanation. Nevertheless, the fact that glucocorticoids prevented these changes and the fact that they occurred within 1 hour argue against the last hypothesis. Glucocorticoids are known to cause protein catabolism and it would be unlikely that they could enhance protein synthesis. Moreover, it is unlikely that reduced protein synthesis would have a marked effect on enzyme turnover within 1 hour.
The alteration in plasma membrane chemistry occurs even earlier than comparable changes in lysosomes. We were unable to obtain a purified lysosomal fraction using the sucrose density gradient of Kidwai. 7 High cathepsin D activities were present in the F,, F l t and F s fractions, with modest activity in the F 4 and F B fractions of normal and ischemic cardiac tissue. This would tend to confirm the observation of Hoffstein et al. 2 ' that lysosomal hydrolases are present to a large extent in the sarcoplasmic reticulum of the heart, and from the sarcoplasmic reticulum can infiltrate other portions of the cytoplasm. This type of distribution precluded any study of the integrity or sensitivity of lysosomes in our experimental model.
Both glucocorticoids were studied in concentrations equivalent to doses usually recommended for treatment of circulatory shock or acute myocardial infarction (i.e., MP, 30 mg/kg, and Dex, 8 mg/kg). la Dex and MP exhibited comparable total uptakes and a similar subcellular distribution in most of the five sucrose density gradient fractions indicating comparable total uptake rates by myocardial cells. However, the F, fraction which contains many of the light lysosomes and mitochondria 7 incorporated significantly greater (P < 0.02) 'H-MP than 'H-Dex in all three myocardial areas. This may indicate that MP is preferentially incorporated into myocardial lysosomes in comparison to Dex. Whether this finding is a chance observation or whether it relates to important differences in myocardial cell function remains to be shown. In this regard, it is possible that the large localization of glucocorticoid in plasma and lysosomal membranes is not related to the mechanism of action of these agents in acute myocardial ischemia. Thus, a small amount of glucocorticoid taken up by some other structure (i.e., nucleus, sarcoplasmic reticulum, etc.) may be important in the overall protective effect. Nevertheless, plasma and lysosomal membrane stabilization appears to be a real possibility as the mechanism of glucocorticoid protection in myocardial ischemia. Moreover, since we administered glucocorticoid at the time of coronary artery occlusion, our results may not be directly comparable to clinical states, in which drugs are given up to several hours after acute myocardial ischemia. However, the fact that glucocorticoids have been shown to be effective 1-6 hours after coronary artery occlusion 1 -12 would tend to minimize these differences.
Finally, our results were obtained in hearts perfused with Krebs-Henseleit solution rather than blood. In an effort to VOL. 39, No. 5, NOVEMBER 1976 determine whether this buffer could substantially alter the uptake of glucocorticoid, we measured 'H-MP uptake in two cat hearts in situ perfused by the cat's own coronary flow. One hour after occlusion of the left anterior coronary artery, steroid uptake was measured. The mean uptake in //mol/g of tissue was 1.21 in nonischemic tissue, 1.03 in the border zone, and 0.87 in the ischemic area. These values are approximately 20% lower than in the hearts perfused with Krebs-Henseleit solution, but indicate that the uptake process appears to be similar in magnitude to that occurring in the hearts perfused with Krebs-Henseleit solution.
